Regulatory effect of Chinese herbal medicines on gastrointestinal hormones and motility

World Chinese Journal of Digestology

Volumn 8, Issue 10, 2000, Pages 1141-1144

  Zhang, H X ^a   Ren, P ^a   Huang, X ^a   Li, Y ^a  

^a NONE

Author keywords

Drugs, Chinese herbal; Gastrins; Gastrointestinal diseases; Gastrointestinal hormones; Gastrointestinal motility; Intestinal peptide; Vasoactive

Indexed keywords

CHOLECYSTOKININ; GASTRIN; GASTROINTESTINAL HORMONE; HERBACEOUS AGENT; MOTILIN; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

CHINESE MEDICINE; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFECT; GASTROINTESTINAL MOTILITY; HERBAL MEDICINE; HORMONE RELEASE; HUMAN; NONHUMAN; REGULATORY MECHANISM; REVIEW;

EID: 0033785310     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. 5-(Trytophyl) amino-1,3-dioxoperhydropyrido[1,2-c] pyrimidine-based potent and selective CCK(1) receptor antagonists: Structural modifications at the tryptophan domain
2. Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy
3. Distal small bowel hormones: Correlation with fasting antroduodenal motility and gastric emptying
4. Intraduodenal neuropeptide levels, but not plasma levels, vary in a cyclic fashion with the migrating motor complex
5. Localization of somatostatin receptor subtype mRNA in the rat gastrointestinal tract and relation of SSTR1 gene expression
6. Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastrointestinal samples: Where are they really located?
7. Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor
8. Somatostatin receptors present knowledge and future directions
9. Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: Peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons
10. Somatostatin receptor ligands and their use in the treatment of endocrine disorders
11. Localization of somatostatin receptor subtype mRNA in the rat gastrointestinal tract and regulation of SSTR1 gene expression
12. The evaluation of the role of CCK in the opioid modulation of the motility of the gastrointestinal tract in sheep
13. Cholecystokinin cells
14. Evidence for CCK (B) receptors in the guinea-pig kidney: Localization and characterization by [125I] gastrin binding studies and by RT-PCR
15. The somatogenic hormones and insulin-like growth factor-1: Stimulators of lymphopoiesis and immune function
16. Peptide YY and the Y2 agonist PYY -(13-36) inhibit neurons of the dorsal motor nucleus of the vagus
17. Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue
18. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor
19. Unusual peptide-secreting tumors in adolescents and children
20. Effects of age on Concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility
21. The somatostatin receptor subtype 2 is expressed in normal and tumoral human tissues 70